{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:54:22Z","timestamp":1790679262782,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.2215\/cjn.08091109","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T22:51:13Z","timestamp":1262904673000},"page":"365-370","source":"Crossref","is-referenced-by-count":36,"title":["Assessment of Renal Pathology and Dysfunction in Children with Fabry Disease"],"prefix":"10.2215","volume":"5","author":[{"given":"Uma","family":"Ramaswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Najafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo","family":"Schieppati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Bichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-33-20230601","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: Influence of alpha-galactosidase A activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine (Baltimore"},{"key":"R2-33-20230601","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","article-title":"Nephropathy in males and females with Fabry disease: Cross-sectional description of patients before treatment with enzyme replacement therapy","volume":"23","author":"Ortiz","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R3-33-20230601","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: Progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R4-33-20230601","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"R5-33-20230601","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0272-6386(83)80047-X","article-title":"Early renal failure in Fabry's disease","volume":"2","author":"Sheth","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"R6-33-20230601","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000059897","article-title":"Kidney involvement in Anderson-Fabry disease","volume":"122","author":"Meroni","year":"1997","journal-title":"Contrib Nephrol"},{"key":"R7-33-20230601","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1023\/A:1012423924648","article-title":"Renal pathological changes in Fabry disease","volume":"24","author":"Sessa","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"R8-33-20230601","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","article-title":"Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria","volume":"51","author":"Tondel","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R9-33-20230601","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1651-2227.2007.00029.x","article-title":"Enzyme replacement therapy with agalsidase alfa in children with Fabry disease","volume":"96","author":"Ramaswami","year":"2007","journal-title":"Acta Paediatr"},{"key":"R10-33-20230601","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2005-2895","article-title":"Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease","volume":"118","author":"Ries","year":"2006","journal-title":"Pediatrics"},{"key":"R11-33-20230601","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpeds.2007.09.007","article-title":"Safety and efficacy of enzyme replacement therapy with agalsidase beta: An international, open-label study in pediatric patients with Fabry disease","volume":"152","author":"Wraith","year":"2008","journal-title":"J Pediatr"},{"key":"R12-33-20230601","first-page":"823","article-title":"Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease","volume":"2","author":"Fervenza","year":"2008","journal-title":"Biologics"},{"key":"R14-33-20230601","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/physrev.00055.2006","article-title":"Properties of the glomerular barrier and mechanisms of proteinuria","volume":"88","author":"Haraldsson","year":"2008","journal-title":"Physiol Rev"},{"key":"R15-33-20230601","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","article-title":"Cellular and tissue localization of globotriaosylceramide in Fabry disease","volume":"451","author":"Askari","year":"2007","journal-title":"Virchows Arch"},{"key":"R16-33-20230601","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ki.1978.32","article-title":"Early renal changes in hemizygous and heterozygous patients with Fabry's disease","volume":"13","author":"Gubler","year":"1978","journal-title":"Kidney Int"},{"key":"R17-33-20230601","first-page":"7","article-title":"Fetal pathology in Fabry's disease and mucopolysaccharidosis type I [in Czech]","volume":"34","author":"Elleder","year":"1998","journal-title":"Cesk Patol"},{"key":"R18-33-20230601","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1447-0756.1985.tb00045.x","article-title":"Early prenatal diagnosis of inborn error of metabolism: A case report of a fetus affected with Fabry's disease","volume":"11","author":"Tsutsumi","year":"1985","journal-title":"Asia Oceania J Obstet Gynaecol"},{"key":"R19-33-20230601","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"64","author":"Hopkin","year":"2008","journal-title":"Pediatr Res"},{"key":"R20-33-20230601","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08035250500275022","article-title":"Clinical manifestations of Fabry disease in children: Data from the Fabry Outcome Survey","volume":"95","author":"Ramaswami","year":"2006","journal-title":"Acta Paediatr"},{"key":"R21-33-20230601","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1542\/peds.2004-1678","article-title":"Pediatric Fabry disease","volume":"115","author":"Ries","year":"2005","journal-title":"Pediatrics"},{"key":"R22-33-20230601","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: A study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur J Pediatr"},{"key":"R23-33-20230601","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"R24-33-20230601","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"R25-33-20230601","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-3476(85)80697-1","article-title":"A simple estimate of glomerular filtration rate in adolescent boys","volume":"106","author":"Schwartz","year":"1985","journal-title":"J Pediatr"},{"key":"R26-33-20230601","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"R27-33-20230601","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"R28-33-20230601","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5414\/CNP71118","article-title":"The MDRD equation may mask decline of glomerular filtration rate in Fabry patients with normal or nearly normal kidney function","volume":"71","author":"Aakre","year":"2009","journal-title":"Clin Nephrol"},{"key":"R29-33-20230601","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.2008080870","article-title":"Agalsidase alfa and kidney dysfunction in Fabry disease","volume":"20","author":"West","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R30-33-20230601","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1258\/0004563053026899","article-title":"Susceptibility of glomerular filtration rate estimations to variations in creatinine methodology: A study in older patients","volume":"42","author":"Lamb","year":"2005","journal-title":"Ann Clin Biochem"},{"key":"R31-33-20230601","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1373\/clinchem.2008.116863","article-title":"Prime time for enzymatic creatinine methods in pediatrics","volume":"55","author":"Cobbaert","year":"2009","journal-title":"Clin Chem"},{"key":"R32-33-20230601","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ndt\/gfn306","article-title":"How to estimate GFR in children","volume":"24","author":"Delanghe","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R33-33-20230601","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R34-33-20230601","first-page":"875","article-title":"Estimation of glomerular filtration rate from plasma creatinine concentration in children","volume":"51","author":"Counahan","year":"1976","journal-title":"Arch Intern Med"},{"key":"R35-33-20230601","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","article-title":"Fabry disease in childhood","volume":"144","author":"Desnick","year":"2004","journal-title":"J Pediatr"},{"key":"R36-33-20230601","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2215\/CJN.01640309","article-title":"Measurement and estimation of GFR in children and adolescents.","volume":"4","author":"Schwartz","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R38-33-20230601","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy.","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"},{"key":"R39-33-20230601","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.2006080816","article-title":"Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease","volume":"18","author":"Germain","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R40-33-20230601","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfi152","article-title":"Long-term therapy with agalsidase alfa for Fabry disease: Safety and effects on renal function in a home infusion setting","volume":"21","author":"Schiffmann","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R41-33-20230601","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1681\/ASN.2006111263","article-title":"Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing","volume":"18","author":"Schiffmann","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R42-33-20230601","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1681\/ASN.2006080822","article-title":"Distribution of alpha-galactosidase A in normal human kidney and renal accumulation and distribution of recombinant alpha-galactosidase A in Fabry mice","volume":"18","author":"Christensen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R43-33-20230601","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: Diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"R44-33-20230601","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00467-007-0447-9","article-title":"Outcomes of children with proliferative lupus nephritis: The role of protocol renal biopsy","volume":"22","author":"Askenazi","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R45-33-20230601","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1399-3046.2007.00705.x","article-title":"Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients","volume":"11","author":"Hymes","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R46-33-20230601","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s00467-005-1879-8","article-title":"Childhood thin GBM disease: Review of 22 children with family studies and long-term follow-up","volume":"20","author":"Carasi","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"R47-33-20230601","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2214\/AJR.08.1743","article-title":"Radiologist-supervised ketamine sedation for solid organ biopsies in children and adolescents","volume":"192","author":"Mason","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"R48-33-20230601","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.2337\/diabetes.51.5.1572","article-title":"The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants","volume":"51","author":"Mauer","year":"2002","journal-title":"Diabetes"},{"key":"R50-33-20230601","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"R51-33-20230601","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.54.7.2164","article-title":"The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients","volume":"54","author":"Steinke","year":"2005","journal-title":"Diabetes"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201002000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:18Z","timestamp":1786369158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201002000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.08091109","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}